[
    [
        {
            "time": "2023-03-15",
            "original_text": "FDA Okays Lilly's Alzheimer's Disease Diagnostic Agent Tauvid",
            "features": {
                "keywords": [
                    "FDA",
                    "Lilly",
                    "Alzheimer's",
                    "Tauvid",
                    "diagnostic"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "FDA Okays Lilly's Alzheimer's Disease Diagnostic Agent Tauvid",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-03-15",
            "original_text": "Lilly Cleared by FDA to Market Alzheimer's Detection Drug",
            "features": {
                "keywords": [
                    "Lilly",
                    "FDA",
                    "market",
                    "Alzheimer's",
                    "detection"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Lilly Cleared by FDA to Market Alzheimer's Detection Drug",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-03-15",
            "original_text": "Pharma Stock Roundup: MRK, RHHBY Give Coronavirus Updates, SNY to Sell Stake in REGN",
            "features": {
                "keywords": [
                    "Pharma",
                    "MRK",
                    "RHHBY",
                    "SNY",
                    "REGN",
                    "Coronavirus"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "mixed",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Pharma Stock Roundup: MRK, RHHBY Give Coronavirus Updates, SNY to Sell Stake in REGN",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-03-15",
            "original_text": "Veeva Systems (VEEV) Q1 Earnings and Revenues Beat Estimates",
            "features": {
                "keywords": [
                    "Veeva",
                    "Systems",
                    "Q1",
                    "earnings",
                    "revenues",
                    "beat",
                    "estimates"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "technology",
                    "software"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Veeva Systems (VEEV) Q1 Earnings and Revenues Beat Estimates",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 10,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "2023-03-15",
            "original_text": "Lilly gets FDA approval for Alzheimer's diagnostic agent",
            "features": {
                "keywords": [
                    "Lilly",
                    "FDA",
                    "approval",
                    "Alzheimer's",
                    "diagnostic"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Lilly gets FDA approval for Alzheimer's diagnostic agent",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-03-15",
            "original_text": "Eli Lilly Earns Landmark Approval for Alzheimer's Disease Imaging Agent",
            "features": {
                "keywords": [
                    "Eli",
                    "Lilly",
                    "Landmark",
                    "Approval",
                    "Alzheimer's",
                    "Imaging"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Eli Lilly Earns Landmark Approval for Alzheimer's Disease Imaging Agent",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        }
    ]
]